0000000000529586

AUTHOR

Serena Camerini

0000-0001-6131-4335

showing 2 related works from this author

Effects of indole-3-acetic acid on Sinorhizobium meliloti survival and on symbiotic nitrogen fixation and stem dry weight production

2009

We evaluated the effects of the main auxin phytohormone, indole-3-acetic acid (IAA), on the central metabolism of Sinorhizobium meliloti strain 1021. We either treated the Sinorhizobium meliloti 1021 strain with 0.5 mM IAA (1021+) or use a derivative, RD64, of the same strain harbouring a pathway for IAA biosynthesis converting tryptophan into IAA via indoleacetamide. We assayed the activity of key enzymes in the major energy-yielding pathways (Entner-Doudoroff, Embden-Meyerhof-Parnas, pentose phosphate, glyoxylate bypass and tricarboxylic acid cycle). We found that activity of two main regulative tricarboxylic acid (TCA) cycle enzymes was increased. Citrate synthase (CS) activity, as compa…

PolyestersHydroxybutyratesDehydrogenaseCitrate (si)-SynthaseApplied Microbiology and BiotechnologyCell survival . PHB . TCA . Nitrogen fixationchemistry.chemical_compoundBacterial ProteinsPlant Growth RegulatorsAcetyl Coenzyme AAuxinNitrogen FixationMedicago truncatulaCitrate synthaseKetoglutarate Dehydrogenase ComplexBiomasschemistry.chemical_classificationSinorhizobium melilotiMicrobial ViabilityIndoleacetic AcidsPlant StemsbiologyTryptophanfood and beveragesGeneral MedicineMetabolismbiology.organism_classificationCitric acid cycleBiochemistrychemistrybiology.proteinIndole-3-acetic acidSinorhizobium melilotiBiotechnologyApplied Microbiology and Biotechnology
researchProduct

proNGF Measurement in Cerebrospinal Fluid Samples of a Large Cohort of Living Patients With Alzheimer's Disease by a New Automated Immunoassay

2021

The discovery of new biomarkers for Alzheimer's disease (AD) is essential for an accurate diagnosis, to conceive new strategies of treatments, and for monitoring the efficacy of potential disease-modifying therapies in clinical trials. proNGF levels in the cerebrospinal fluid (CSF) represent a promising diagnostic biomarker for AD, but its validation was hampered by the absence of a reliable immunoassay. In the literature, proNGF is currently measured in postmortem brain tissue by semiquantitative immunoblot. Here we describe the development and validation of a new method to measure proNGF in the CSF of living patients. This method, based on molecular size separation by capillary electropho…

OncologyAgingmedicine.medical_specialtydiagnosisCognitive NeuroscienceNeurosciences. Biological psychiatry. NeuropsychiatryDiseaseSettore BIO/09 - FisiologiaCerebrospinal fluidneurodegenerative diseaseInternal medicinemedicineDiagnostic biomarkerneurodegenerative diseasesproNGFimmunoassayOriginal Researchmedicine.diagnostic_testbusiness.industrySignificant differenceAlzheimer's diseaseLarge cohortdiagnosiImmunoassayBiomarker (medicine)biomarkerAutomated immunoassaybusinessRC321-571Neuroscience
researchProduct